(Q58844223)

English

Suramin, an experimental chemotherapeutic drug, irreversibly blocks T cell CD45-protein tyrosine phosphatase in vitro

scientific article published on 01 July 1993

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8333852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8333852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

title

Suramin, an experimental chemotherapeutic drug, irreversibly blocks T cell CD45-protein tyrosine phosphatase in vitro (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8333852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8333852%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

1 reference

Ghosh J

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8333852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8333852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

Miller RA

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8333852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8333852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

language of work or name

English

0 references

publication date

1 July 1993

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8333852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8333852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

published in

Biochemical and Biophysical Research Communications

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8333852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8333852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

volume

194

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8333852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8333852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8333852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8333852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

page(s)

36-44

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8333852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8333852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

Identifiers

DOI

10.1006/BBRC.1993.1781

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8333852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8333852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 October 2019

PubMed publication ID

8333852

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8333852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8333852%20AND%20SRC:MED&resulttype=core&format=json

(Q58844223)

Suramin, an experimental chemotherapeutic drug, irreversibly blocks T cell CD45-protein tyrosine phosphatase in vitro

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)